Ronald J Buckanovich

13PUBLICATIONS
103CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersChemotherapyMolecular targetsTumour immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Aug 13, 2026
Targeting HDAC and proteostasis to eradicate quiescent cancer cells.

|Apr 16, 2026
RHOV Is a Detachment-Responsive Rho GTPase Necessary for Ovarian Cancer Peritoneal Metastasis.

|Aug 20, 2025
RHOV is a Detachment-Responsive Rho GTPase Necessary for Ovarian Cancer Peritoneal Metastasis.

Amal T Elhaw, Priscilla W Tang, Ya-Yun Cheng

|Mar 14, 2025
Aged and BRCA-Mutated Stromal Cells Drive Epithelial Cell Transformation.

Geyon L Garcia, Taylor Orellana, Grace Gorecki

|Feb 24, 2025
Role of the NuRD complex and altered proteostasis in cancer cell quiescence.

Qi Jiang, Michelle Ertel, Austin Arrigo

|May 22, 2024
Phase I and Randomized Phase II Study of Ruxolitinib With Frontline Neoadjuvant Therapy in Advanced Ovarian Cancer: An NRG Oncology Group Study.

Charles N Landen, Ronald J Buckanovich, Michael W Sill

Pageof 3

Frequent Collaborators

6 joint publications

Lan G Coffman

3 joint publications

Amal Taher Elhaw

3 joint publications

Nadine Hempel

3 joint publications

Tullia C Bruno